BromAc

· Mucpharm Pty Ltd

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BromAc, covering 2022-02-28 to 2022-03-15. Get the full timeline:

Most recent: Clinical Trial Update: BromAc for Recurrent Peritoneal Mucinous Tumour or Pseudomyxoma Peritonei [Phase 2]